Efficacy of IL12/23 Blockade Expands Our Therapeutic Targets and Challenges the Old Dogma in Ulcerative Colitis.

Bamias, Giorgos; Rivera-Nieves, Jesús; Mantzaris, Gerassimos J

Bamias, Giorgos; Rivera-Nieves, Jesús; Mantzaris, Gerassimos J.

Afiliação

Bamias G; GI-Unit, 3(rd) Academic Department of Internal Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Rivera-Nieves J; Department of Medicine, Division of Gastroenterology, San Diego, California.
Mantzaris GJ; Department of Gastroenterology, Evangelismos, Ophthalmiatreion Athinon and Polyclinic Hospitals, Athens, Greece.

Gastroenterology ; 158(6): 1836-1837, 2020 05.

Article em En | MEDLINE | ID: mdl-32199882

Assuntos

Colite Ulcerativa; Humanos; Interleucina-12; Ustekinumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google